ARCHIVES

PROPOC Study Analyses Six Cancer DRGs

This article is from The Cancer Letter archive.

Vol. 12 No. 03 | January 17, 1986

Download PDF Visit The Full Archive

Related Articles

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers

February 7, 1997

Cancer Act Renewal Nears Vote By House

August 11, 1978

June issue of Business & Regulatory Report included.

July 2, 2004

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014